Physical Therapy for Osteoarthritis
(TeMPO Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines the best physical therapy methods for individuals with knee osteoarthritis and meniscal tears (a tear in the knee's cartilage). Researchers compare four different therapy plans: the TeMPO Home Exercise Program (a home-based exercise regimen), in-clinic exercise therapy, in-clinic topical therapy, and motivational text messages to boost adherence. The goal is to determine which combination most effectively reduces pain and improves knee function. Individuals with a doctor's diagnosis of a meniscal tear and signs of knee osteoarthritis on imaging may be suitable candidates for this trial. As an unphased trial, this study provides an opportunity to explore innovative therapy combinations that could enhance quality of life.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are using strong opioids daily or have had intra-articular therapy in the last 4 weeks, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Past studies have shown that physical therapy and exercise are safe for individuals with knee osteoarthritis, including those with meniscal tears. Research indicates that exercise therapy is a well-tolerated treatment option that helps manage pain and improve function without major side effects.
For exercise therapies conducted in clinics, studies confirm their safety and effectiveness in treating knee osteoarthritis. These therapies are often recommended because they are non-invasive and carry a low risk of side effects.
Topical treatments, such as creams or gels applied to the skin, are also safe and have fewer side effects compared to oral medications, particularly concerning stomach-related issues.
Motivational text messages, used to encourage adherence to exercise routines, have been tested and are safe. They effectively help patients manage their condition by promoting regular physical activity.
Overall, the treatments tested in this trial have a strong safety record based on previous research. Participants can expect these therapies to be safe with a low risk of serious side effects.12345Why are researchers excited about this trial?
Researchers are excited about the TeMPO Home Exercise Program for osteoarthritis because it offers a structured, at-home physical therapy routine that includes weights, a detailed instructional DVD, and pamphlets. This program goes beyond typical exercise routines by incorporating motivational SMS messages, which aim to boost adherence and engagement. Additionally, some participants benefit from in-clinic sessions where therapists provide personalized guidance and apply topical therapies like ultrasound and gel, potentially enhancing the benefits of the exercises. Unlike many standard care options that focus solely on pain relief, this approach emphasizes building strength and flexibility, which could lead to more sustainable improvements in joint function.
What evidence suggests that this trial's physical therapy regimens could be effective for knee osteoarthritis and meniscal tears?
Research has shown that physical therapy can be as effective as surgery for treating knee osteoarthritis with meniscal tears. Home exercises can significantly relieve pain and improve knee function. In this trial, participants in the Home Exercise Program arm will receive the TeMPO Home Exercise Program. Another arm, Home Exercise Program + SMS Messages, will include motivational text messages to encourage adherence to the exercise regimen.
Studies also indicate that exercising in a clinic can help manage knee pain, and combining these with home exercises might enhance the benefits. Participants in the In-Clinic Exercise Therapy arm will receive both the TeMPO Home Exercise Program and in-clinic sessions with a physical therapist. For treatments applied directly to the skin, evidence supports that gels can effectively reduce pain and stiffness. The In-Clinic Topical Therapy arm will include these topical therapies alongside the TeMPO Home Exercise Program.
While motivational text messages have shown mixed results, some studies suggest they might help people stick to their exercise routines and manage pain better. Overall, each part of the TeMPO program has shown promise in improving symptoms of knee osteoarthritis.13678Who Is on the Research Team?
Chuck Washabaugh, PhD
Principal Investigator
National Institute for Arthritis, Musculoskeletal and Skin Diseases (NIAMS, NIH)
Are You a Good Fit for This Trial?
This trial is for adults aged 45-85 with knee pain from a meniscal tear and osteoarthritis, confirmed by MRI or X-ray. Candidates must have had knee pain for at least 21 days if it's due to injury. Exclusions include inflammatory arthritis, recent knee surgery, pregnancy, MRI contraindications, strong opioid use, recent joint therapy, nursing home residents, dementia history or worker's compensation claimants.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to one of four physical therapy regimens, including home exercises, SMS messages, in-clinic topical therapy, and in-clinic exercise therapy
Follow-up
Participants are monitored for changes in pain, function, and quality of life
Long-term Follow-up
Participants are monitored for durability of pain relief and treatment outcomes
What Are the Treatments Tested in This Trial?
Interventions
- In-Clinic Exercise Therapy
- In-Clinic Topical Therapy
- Motivational SMS Messages
- TeMPO Home Exercise Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brigham and Women's Hospital
Lead Sponsor
State University of New York at Buffalo
Collaborator
National Institutes of Health (NIH)
Collaborator
Boston University
Collaborator
The Cleveland Clinic
Collaborator
University of Pittsburgh
Collaborator
University of Melbourne
Collaborator